NASDAQ : KRMD
KORU Medical Systems, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 3.23 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 149.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 138.05M |
| Enterprise Value | 133.08M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 46.17M |
| Shares Outstanding | 46.17M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +6.78% |
| Owned by Insiders (%) | 7.17% |
| Owned by Institutions (%) | 37.67% |
| Float | 34.41M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 299.00 |
| PS Ratio | 3.06 |
| Forward PS | 2.64 |
| PB Ratio | 7.64 |
| P/TBV Ratio | 8.42 |
| P/FCF Ratio | 177.76 |
| P/OCF Ratio | 99.25 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 171.35 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.72 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | 4.26 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -10.52% |
| Return on Assets (ROA) | -3.86% |
| Return on Invested Capital (ROIC) | -13.44% |
| Return on Capital Employed (ROCE) | -7.95% |
| Weighted Average Cost of Capital (WACC) | 6.22% |
| Revenue Per Employee | $617,911 |
| Profits Per Employee | -$24,924 |
| Employee Count | 73 |
| Asset Turnover | 1.69 |
| Inventory Turnover | 4.01 |
Taxes
| Measure | Value |
|---|
| Income Tax | 10,334 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -24.30% |
| 50-Day Moving Average | 3.13 |
| 200-Day Moving Average | 4.02 |
| Relative Strength Index (RSI) | 42.18 |
| Average Volume (20 Days) | 167,120 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 888,394 |
| Short Previous Month | 907,388 |
| Short % of Shares Out | 1.92% |
| Short % of Float | 2.58% |
| Short Ratio (days to cover) | 3.10 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 45.11M |
| Gross Profit | 28.16M |
| Operating Income | -1.65M |
| Pretax Income | -1.81M |
| Net Income | -1.82M |
| EBITDA | -979,396 |
| EBIT | -1.65M |
| Loss Per Share | -$0.04 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 8.29M |
| Total Debt | 3.31M |
| Net Cash | 4.98M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 18.05M |
| Book Value Per Share | 0.39 |
| Working Capital | 12.33M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.39M |
| Capital Expenditures | -614,335 |
| Depreciation & Amortization | 673,319 |
| Net Borrowing | -121,716 |
| Free Cash Flow | 776,653 |
| FCF Per Share | $0.02 |
Margins
| Measure | Value |
|---|
| Gross Margin | 62.43% |
| Operating Margin | -3.66% |
| Pretax Margin | -4.01% |
| Profit Margin | -4.03% |
| EBITDA Margin | -2.17% |
| EBIT Margin | -3.66% |
| FCF Margin | 1.72% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | -1.34% |
| FCF Yield | 0.56% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $6.25 |
| Price Target Difference | 109.03% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 16.36% |
| EPS Growth Forecast (3Y) | 146.62% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 12.67 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |